Overview
Anti-viral drugs are used to treat viral infections and are the only agents acting against viruses as either other drugs are ineffective or too toxic. The market segment of anti-viral drugs is driven by factors such as rise in healthcare expenditure, growing research and development investment, emergence of virus life-threatening diseases like bird flu, strong development pipeline and increasing incidence rates of viral infections particularly HIV. WHO has estimated that in 2015 about 36.7 million people are suffering from HIV/AIDS with 1.1 million deaths occurring due to AIDS-related illness the emergence of donor funding in the treatment of the disease has also increased the demands of anti-viral drug market. Strong research pipeline coupled with rise in research and development investment will be the market driver of the future.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2454
The constraints on the market include side effects associated with treatment, the cost of the therapy and poor efficacy and effectiveness of the drugs.
Segmentation
The global anti-viral drugs market has been segmented based on application and mechanism of action. By application, the market has been segmented into hepatitis, HIV/AIDS, herpes, influenza and others. By mechanism of action, the market has been segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, and others.
Regional Analysis
The Americas, Europe, Asia Pacific, and Middle East & Africa are the key markets for antiviral drugs. The Americas is the largest market followed by Europe. Growing prevalence of viral infections in the region, the presence of key players in the region and high healthcare expenditure drives the market in the Americas.
The Europe market is driven by the presence of a robust healthcare sector and high investment in R&D activities.
Asia Pacific is slated to be the fastest growing market for anti-viral drugs. Growing prevalence of viral infections in the developing economies of the region coupled with the outlay of massive amounts on healthcare facilities supports the growth of the Asia Pacific market.
Competitive Landscape
The anti-viral drugs market is supported by growing research and development investment. The population growth around the world and increasing demand of anti-viral drugs market based services and products also support the market growth. However, changes in policies and lack of clarity in guidelines can affect the market growth. The report covers all such details which will help companies in the anti-viral drugs market to strengthen their business plan and improve their product portfolio. The anti-viral drugs market research report also provides company profiles of major companies. The company profiles of many organizations operating in the anti-viral drugs market report highlights crucial details like company size, revenue growth, and details of mergers and acquisitions taking place in the anti-viral drugs market. New companies and established businesses can plan their strategies based on this data provided in the anti-viral drugs market research report.
Industry News
NeuroBo Pharmaceuticals, a biotechnology firm, has announced that it has purchased ANA Therapeutics, a privately owned biotechnology company that produces a patented niclosamide capsule formulation for the indication of coronavirus, now in Phase 2/3 clinical trials as a cure for COVID-19. The deal was unanimously approved by both the Boards of Directors of NeuroBo Pharmaceuticals and ANA Therapeutics
Key Players:
The major participants of this market are: Johnson & Johnson, Merck & Co. Inc., Gilead Sciences Inc., Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Abbott Laboratories, Novartis International AG, AstraZeneca AB, Cipla Inc. and others.
List of Tables
TABLE 1 GLOBAL ANTI-VIRAL DRUGS MARKET, 2020-2027 (USD MILLION)
TABLE 2 GLOBAL ANTI-VIRAL DRUGS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL ANTI-VIRAL DRUGS MARKET, BY MECHANISM OF ACTION, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL ANTI-VIRAL DRUGS MARKET, BY REGION, 2020-2027 (USD MILLION)
Browse Complete Report @ https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454
Related reports link:-
Global Hemorrhoid Treatment Devices Market
Veterinary Vaccines Market
Microcarriers Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
Competitive Analysis:The major players operating in the Glass Additives Market include Namibia Rare Earths Inc. (Canada), Lynas Corporation Ltd (Australia), Torrecid Group (Spain), Potters Industries LLC (U.S.), SCHOTT AG (Germany), DuPont.
(U.S.), GILLINDER GLASS (U.S.), METALL RARE EARTH LIMITED (China), Ardagh Group (Republic of Ireland), HAMMOND GROUP INC (U.S.) among others.Access Complete Report @ https://www.marketresearchfuture.com/reports/glass-additives-market-5140Market Segmentation:The Global Glass Additives Market is segmented on the basis of product, application, and region.
On the basis of product, the market is categorized into metal oxide, nanoparticles, and polymers & rare earth metals.
As these are used for coloring and to enhance specific properties such as electrical and thermal conductivity.
As these are mainly used as coating for gadgets, windows, and doors.
Increasing popularity of scratch resistant window panes for mobile phones, automobiles, laptops, and other electronic devices is predicted to surge the market growth.
Market Overview:Increasing demand for dietary supplements and nutritive food & feed is one of the major factors contributing to the growth of the global glycinates market.
Glycinates are serving as an important additive in most of the food, beverage, supplements, and animal feed products.
Availability of glycinates in various forms has influenced the demand from various industries apart from food & feed industry.Access Report Details @ https://www.marketresearchfuture.com/reports/glycinates-market-5546Market Forecast:The global glycinates market share in the foods & feed industry is intensifying by the growing demand for functional food & feed additives in the developed & developing countries.
Increasing prevalence of deficiency diseases among the growing population is found to be a key factor responsible for the growth of glycinates market.Furthermore, improved processing methods and demand for nutritive food products in the developing countries are positively supporting the growth of the global glycinates market.
Additionally, restriction on the use of antibiotics in food & feed formulations in the North American & European region is adding fuel to the market growth.
Downstream analysis:The global glycinates market is segmented into type, form, and application.On the basis of the type, it is segmented into zinc, copper, manganese, magnesium, calcium, sodium, and others.
The Global Sportswear Market is projected to display a robust growth represented by a CAGR of 5.80% during 2018-2023.
Athletic Footwear segment contributed maximum revenue in the market and is expected to continue the leadership in the forecast period on the back of rising awareness regarding the rising awareness of health and wellness, the prevalence of Athleisure trend in developing nations coupled with increasing number gyms, jogging tracks, fitness clubs.
Amidst the Sales Channel, online segment is expected to witness the fastest growth rate on the heels of rising internet penetration and number of smartphone users across the globe.
Amongst the regions, Asia Pacific accounts for the largest regional share in the global sportswear market in 2018.
Key factors driving the robust Asia Pacific market include large population base, increasing disposable income coupled with rising health consciousness across the region.
Global Sportswear Market has covered and analyzed the potential of Global Sportswear Market and provides statistics and information on market size, shares and growth factors.
Market Overview:Increasing demand for dietary supplements and nutritive food & feed is one of the major factors contributing to the growth of the global glycinates market.
Glycinates are serving as an important additive in most of the food, beverage, supplements, and animal feed products.
Availability of glycinates in various forms has influenced the demand from various industries apart from food & feed industry.Competitive analysisThe major players in the glycinates marketAjinomoto Co., Inc. (Japan)Clariant AG (Switzerland)Solvay SA (Belgium)BASF SE (Germany)NovoTech Nutraceuticals Inc. (U.S.)Dunstan Nutrition Ltd. (New Zealand)Shijiazhuang Donghua Jinlong Chemical Co Ltd. (China)Schaumann GmbH & Co. KG.
(Germany)Aliphos Belgium SA/NV (Belgium)Albion Laboratories, Inc. (U.S.)Market Forecast:The global market share in the foods & feed industry is intensifying by the growing demand for functional food & feed additives in the developed & developing countries.
Increasing prevalence of deficiency diseases among the growing population is found to be a key factor responsible for the growth of glycinates market.Furthermore, improved processing methods and demand for nutritive food products in the developing countries are positively supporting the growth of the global market.
Additionally, restriction on the use of antibiotics in food & feed formulations in the North American & European region is adding fuel to the market growth.
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Market Analysis The global biologics market, during the forecast period, will register growth at a CAGR of 6.95%.The market for biologics is set to reach USD 285,520.4 million by 2023.
Analysts have also studied the market to understand potential threats and challenges the market companies could face.
Although the market is poised to grow at a fast pace across product, disease indication, and manufacturing segments, factors such as restrictions in access to capacity could slow down the market's growth worldwide.Market Segmentation The Market Research Future report offers a complete segmental analysis of the biologics market based on manufacturing, disease indication, and product.
Regional AnalysisBy region, the biologics market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific, Europe, and the Middle East and Africa.
Various factors are propelling the growth of the biologics market in the region, such as investments in new facilities for producing drugs for clinical trials, strong economic growth of Canada and the US, and rapid adoption of manufacturing technologies.
India is a major contributor in this region for its massive strides in biologics manufacturing.Key Players Notable players profiled in the biologics market report include GlaxoSmithKline Plc (UK), Eli Lilly and Company (US), Bayer AG (Germany), Sanofi (France), F. Hoffman-La Roche AG (Switzerland), Novartis AG (Switzerland), Amgen (US), Pfizer Inc. (US), AstraZeneca (UK), and AbbVie, Inc. (US).
